Panagene Licenses PNA Tech From Copenhagen Inventor Group | GenomeWeb
NEW YORK (GenomeWeb News) — Panagene has licensed PNA monomers from the Copenhagen Inventor Group that allows Panagene to synthesize, make, and sell peptide nucleic acids, the company said Tuesday.
 
The South Korean company adds this license agreement to a previous one with CIG for patents for PNA custom synthesis.
 
Panagene estimated that it is currently around 5 percent of the DNA/RNA synthesis market and said the new license will enable it to increase this share “significantly.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.